Ultrabright Fluorescent Nanolabels can be Integrated into Lateral Flow Assays for Better Sensitivity
Thinking beyond COVID-19, a team led by Srikanth Singamaneni at the McKelvey School of Engineering developed a new point-of-care diagnostic test that is 1,000 times more sensitive than conventional rapid tests and can quantify concentrations of proteins.
Source: azonano.com